Ying L. Chi
NHC Key Laboratory Of Enteric Pathogenic Microbiology
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Phosphoproteomics of WHO-Priority Fungal Pathogens: Conserved Signaling Architecture, Pathogen-Specific Outputs, and Therapeutic Vulnerabilities.
Journal: Pathogens (Basel, Switzerland)
Published: June 13, 2026
Clinical features, triggers, and risk factors of severe gastrointestinal involvement in anti-NXP2-positive juvenile dermatomyositis: a retrospective cohort study.
Journal: Pediatric rheumatology online journal
Published: February 01, 2026
The macrophage entry mechanism of SARS-CoV-2 mediated by surface CD98/TMPRSS11E complex is associated with the cellular tropism toward proinflammatory M1 and pathogenesis.
Journal: Respiratory research
Published: January 19, 2026
MG132-mediated inhibition of rabies virus replication via the Nrf2/SQSTM1/PINK1/Parkin autophagy pathway.
Journal: Virology journal
Published: December 05, 2025
A novel targeted hybrid capture-NGS assay for sensitive detection of multiplex respiratory pathogens.
Journal: Microbiology spectrum
Published: November 17, 2025
Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trial.
Journal: EClinicalMedicine
Published: November 05, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.
Journal: BMJ (Clinical research ed.)
Published: October 21, 2025
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.
Journal: Signal transduction and targeted therapy
Published: September 26, 2025
Variant-divergent death: Omicron intensifies bystander T-cell apoptosis via GDF15-BCL2L13.
Journal: Cell death discovery
Published: August 30, 2025
IFNα2b modulates anti-tumor immune responses involving STAT3-associated dendritic cell dysfunction in JAK2v617f-positive myeloproliferative neoplasms.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 25, 2025
Last Updated: 09/26/2026